PolyNovo Limited (PNV.AX)
Makes biodegradable medical devices for wound healing and tissue regeneration.
0.88+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-28.7%
The outlook
PNV.AX trades near its 52-week lows with analyst sentiment solidly bullish—the average price target sits about 76% above the current level. The stock is below both its 50- and 200-day moving averages, reflecting recent weakness. Overall sentiment leans neutral despite the optimistic analyst view and stretched valuation metrics.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 8 analysts
Price trendBelow its 50- & 200-day averages
52-week range8% of the way from its 52-week low to high
Price targetAvg target +76% vs current price
Analyst price target
~12-month · 8 analysts1.55average target+76.0% vs now
Now 0.88
Low 1.00High 2.65
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$607.9M
52-wk high
1.67
52-wk low
0.81
50-day avg
1.02
200-day avg
1.07
Trailing P/E
88.0